Literature DB >> 10417621

UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.

C Marschall1, E Lengyel, T Nobutoh, E Braungart, K Douwes, A Simon, V Magdolen, U Reuning, K Degitz.   

Abstract

Keratinocytes synthesize and secrete urokinase-type plasminogen activator, which binds to its specific receptor on keratinocytes. When bound to urokinase-type plasminogen activator receptor, urokinase-type plasminogen activator proteolytically converts surface bound plasminogen to plasmin, which in turn cleaves many extracellular components leading to pericellular proteolysis. The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus. As pemphigus is photoinducible, we investigated the effect of ultraviolet B on urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor expression in the epidermal keratinocyte cell line A431. Ultraviolet B increased cellular and secreted urokinase-type plasminogen activator protein (enzyme-linked immunosorbent assay) and urokinase-type plasminogen activator receptor cell surface expression (flow cytometry) 24 h postirradiation. Northern blot analysis indicated that ultraviolet B increased urokinase-type plasminogen activator receptor mRNA. Compared with a more rapid mRNA induction by epidermal growth factor (maximal after 4 h) the ultraviolet B response was maximal after 24 h and prolonged up to 36 h. The mRNA induction was not dependent on protein synthesis as judged by cycloheximide incubation. Ultraviolet B did not influence urokinase-type plasminogen activator receptor mRNA stability (actinomycin D incubation). A transiently transfected chloramphenicol acetyltransferase-reporter construct containing a -398/+51 urokinase-type plasminogen activator receptor promoter fragment was activated when cells were exposed to ultraviolet B. This induction was almost completely abolished by mutating a -182/-176 AP-1 binding sequence. Ultraviolet B increased the binding capacity at this AP-1 motif in electrophoretic mobility shift assays. These data identify a distinct transcriptional mechanism by which ultraviolet B induces urokinase-type plasminogen activator receptor. The epidermal induction of components of the proteolytic urokinase system by ultraviolet B may help explain the photoinducibility of pemphigus lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417621     DOI: 10.1046/j.1523-1747.1999.00631.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway.

Authors:  Pierre Vantourout; Carrie Willcox; Andrea Turner; Chad M Swanson; Yasmin Haque; Olga Sobolev; Anita Grigoriadis; Andrew Tutt; Adrian Hayday
Journal:  Sci Transl Med       Date:  2014-04-09       Impact factor: 17.956

2.  Acute UV irradiation increases heparan sulfate proteoglycan levels in human skin.

Authors:  Ji-Yong Jung; Jang-Hee Oh; Yeon Kyung Kim; Mi Hee Shin; Dayae Lee; Jin Ho Chung
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

3.  Heparanase Inhibitors Facilitate the Assembly of the Basement Membrane in Artificial Skin.

Authors:  Makoto Tsunenaga
Journal:  Curr Tissue Eng       Date:  2016-08

4.  Expression and ultrastructural localization of plasmin(ogen) in the terminally differentiated layers of normal human epidermis.

Authors:  R Voegeli; A V Rawlings; M Haftek
Journal:  Int J Cosmet Sci       Date:  2019-12       Impact factor: 2.970

5.  Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma.

Authors:  Elahe Minaei; Simon A Mueller; Bruce Ashford; Amarinder Singh Thind; Jenny Mitchell; Jay R Perry; Benjamin Genenger; Jonathan R Clark; Ruta Gupta; Marie Ranson
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.